159 related articles for article (PubMed ID: 12325100)
21. Maintaining confidentiality of interim data to enhance trial integrity and credibility.
Fleming TR; Sharples K; McCall J; Moore A; Rodgers A; Stewart R
Clin Trials; 2008; 5(2):157-67. PubMed ID: 18375654
[TBL] [Abstract][Full Text] [Related]
22. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
23. Playing safe and preserving integrity: making the FDA model work.
Wittes J
Stat Med; 2004 May; 23(10):1523-5. PubMed ID: 15122731
[TBL] [Abstract][Full Text] [Related]
24. Small sample approach, and statistical and epidemiological aspects.
Offringa M; van der Lee H
Handb Exp Pharmacol; 2011; 205():181-202. PubMed ID: 21882112
[TBL] [Abstract][Full Text] [Related]
25. On the independence of data monitoring committee in adaptive design clinical trials.
Chow SC; Corey R; Lin M
J Biopharm Stat; 2012; 22(4):853-67. PubMed ID: 22651119
[TBL] [Abstract][Full Text] [Related]
26. Stopping guidelines for harm in a study designed to establish the safety of a marketed drug.
Fleishman AN; Parker RA
J Biopharm Stat; 2012; 22(2):338-50. PubMed ID: 22251178
[TBL] [Abstract][Full Text] [Related]
27. Ethical issues in cooperative cancer therapy trials from a statistical viewpoint. II. Specific issues.
Shuster JJ; Krischer JP; Boyett JM
Am J Pediatr Hematol Oncol; 1985; 7(1):64-70. PubMed ID: 4037245
[TBL] [Abstract][Full Text] [Related]
28. Data monitoring committees, interim analysis and early termination in paediatric trials.
Fernandes RM; van der Lee JH; Offringa M
Acta Paediatr; 2011 Oct; 100(10):1386-92. PubMed ID: 21434998
[TBL] [Abstract][Full Text] [Related]
29. Independence of the statistician who analyses unblinded data.
Siegel JP; O'Neill RT; Temple R; Campbell G; Foulkes MA
Stat Med; 2004 May; 23(10):1527-9. PubMed ID: 15122732
[TBL] [Abstract][Full Text] [Related]
30. Refining the postmenopausal breast cancer treatment paradigm: the FACE trial.
Monnier A
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1355-9. PubMed ID: 17069521
[TBL] [Abstract][Full Text] [Related]
31. Management and interpretation of data obtained from clinical trials in pain management.
Theodore BR; Gatchel RJ
Pain Pract; 2008; 8(6):461-72. PubMed ID: 19000174
[TBL] [Abstract][Full Text] [Related]
32. [DSMB. 1. What role, what responsibilities?].
Brun-Buisson C
Med Sci (Paris); 2005 Jan; 21(1):78-82. PubMed ID: 15639025
[TBL] [Abstract][Full Text] [Related]
33. Who's minding the data? Data Monitoring Committees in clinical cancer trials.
Keating P; Cambrosio A
Sociol Health Illn; 2009 Apr; 31(3):325-42. PubMed ID: 19055588
[TBL] [Abstract][Full Text] [Related]
34. Ethical issues arising when interim data in clinical trials is restricted to independent data monitoring committees.
Wells RJ; Gartside PS; McHenry CL
IRB; 2000 Jan; 22(1):7-11. PubMed ID: 12546010
[No Abstract] [Full Text] [Related]
35. Ethical issues in the NIMH Collaborative HIV/STD Prevention Trial.
NIMH Collaborative HIV/STD Prevention Trial Group
AIDS; 2007 Apr; 21 Suppl 2():S69-80. PubMed ID: 17413266
[TBL] [Abstract][Full Text] [Related]
36. Issues in clinical trial design: stopping a trial early and the large and simple trial.
Thom EA; Klebanoff MA
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):619-25. PubMed ID: 16150252
[TBL] [Abstract][Full Text] [Related]
37. Monitoring and safety assessment in Phase I to III clinical trials.
Fescharek R; Nicolay U; Arras-Reiter C
Dev Biol Stand; 1998; 95():203-9. PubMed ID: 9855433
[TBL] [Abstract][Full Text] [Related]
38. How to construct an optimal interim report: What the data monitoring committee does and doesn't need to know.
Neaton JD; Grund B; Wentworth D
Clin Trials; 2018 Aug; 15(4):359-365. PubMed ID: 29552920
[TBL] [Abstract][Full Text] [Related]
39. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
40. Design of randomized controlled trials.
Stanley K
Circulation; 2007 Mar; 115(9):1164-9. PubMed ID: 17339574
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
